Public trial registry of the CCC-Munich

Trial TRIO33_NATALEE

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
TRIO33_NATALEE
World
Full title
:

A phase III, multicenter, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, early breast cancer (New Adjuvant TriAl with Ribociclib [LEE011]:

World
Responsible organization
:
Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Breastcancer
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Hormon,Zielgerichtet - Therapieart: adjuvant

Participants
Function Prename Surname Organization
World Responsible contact Johannes Ettl Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany Magnifier